Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes of Shareholders Equity

v3.23.2
Condensed Statements of Changes of Shareholders Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balances, Beginning at Dec. 31, 2021 $ 833 $ 58,425,604 $ (43,925,373)   $ 14,501,064
Balances, Beginning (in shares) at Dec. 31, 2021 8,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   131,906     131,906
Net loss     (3,960,308)   (3,960,308)
Balances, Ending at Mar. 31, 2022 $ 833 58,557,510 (47,885,681)   10,672,662
Balances, Ending (in shares) at Mar. 31, 2022 8,330,390        
Balances, Beginning at Dec. 31, 2021 $ 833 58,425,604 (43,925,373)   14,501,064
Balances, Beginning (in shares) at Dec. 31, 2021 8,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (7,627,563)
Balances, Ending at Jun. 30, 2022 $ 833 58,694,467 (51,552,936)   7,142,364
Balances, Ending (in shares) at Jun. 30, 2022 8,330,390        
Balances, Beginning at Mar. 31, 2022 $ 833 58,557,510 (47,885,681)   10,672,662
Balances, Beginning (in shares) at Mar. 31, 2022 8,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   136,957     136,957
Net loss     (3,667,255)   (3,667,255)
Balances, Ending at Jun. 30, 2022 $ 833 58,694,467 (51,552,936)   7,142,364
Balances, Ending (in shares) at Jun. 30, 2022 8,330,390        
Balances, Beginning at Dec. 31, 2022 $ 1,833 63,497,868 (56,173,207)   7,326,494
Balances, Beginning (in shares) at Dec. 31, 2022 18,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   161,697     161,697
Net loss     (1,516,864)   (1,516,864)
Balances, Ending at Mar. 31, 2023 $ 1,833 63,659,565 (57,690,071)   5,971,327
Balances, Ending (in shares) at Mar. 31, 2023 18,330,390        
Balances, Beginning at Dec. 31, 2022 $ 1,833 63,497,868 (56,173,207)   $ 7,326,494
Balances, Beginning (in shares) at Dec. 31, 2022 18,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants (in shares)         278,065
Shares surrendered in cashless warrant exercises         $ (292,255)
Net loss         (2,957,768)
Balances, Ending at Jun. 30, 2023 $ 1,861 64,113,437 (59,130,975) $ (292,236) 4,692,087
Balances, Ending (in shares) at Jun. 30, 2023 18,608,455        
Balances, Beginning at Mar. 31, 2023 $ 1,833 63,659,565 (57,690,071)   5,971,327
Balances, Beginning (in shares) at Mar. 31, 2023 18,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants $ 47 292,208     292,255
Exercise of warrants (in shares) 467,625        
Shares surrendered in cashless warrant exercises $ (19)     (292,236) $ (292,255)
Shares surrendered in cashless warrant exercises (in shares) (189,560)       189,560
Share-based compensation expense   161,664     $ 161,664
Net loss     (1,440,904)   (1,440,904)
Balances, Ending at Jun. 30, 2023 $ 1,861 $ 64,113,437 $ (59,130,975) $ (292,236) $ 4,692,087
Balances, Ending (in shares) at Jun. 30, 2023 18,608,455